Investigational drug restores calcium levels in rare genetic disorder

An investigational drug, encaleret, restored calcium levels in people with autosomal dominant hypocalcemia type 1 (ADH1), a rare genetic disorder marked by an imbalance of calcium in the blood and urine, as well as abnormally low levels of parathyroid hormone, which regulates blood calcium levels.

Idaho Medical Group May Close if It’s Not Sold

As the healthcare landscape continues to shift nationwide, Idaho’s Saltzer Health, which was recently acquired by Salt Lake City-based Intermountain Healthcare, is set to shutter

January 26, 2024

Comprehensive analysis of more than 2 million SARS-CoV-2 samples detects co-infections and intra-host recombination

Researchers evaluated the prevalence of co-infection and intra-host recombination in over 2 million global SARS-CoV-2 cases and developed strategies for accurate identification and analysis of

January 17, 2024

Current jargon on antibiotic resistance fails to stick or scare, study finds

Researchers find that current terminology related to antimicrobial resistance (AMR) fails to effectively communicate the risks to the public. The study reveals that terms like

October 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.